Examkin

Soru

Zorluk: OrtaGynecologic Infections

An otherwise healthy 26-year-old woman presents to the ambulatory care center complaining of pelvic pain and abnormal vaginal discharge that began 3 days ago. She describes the pain as a dull, continuous ache in her lower abdomen that worsens with intercourse. She denies any nausea, vomiting, or subjective fever. Her medical history is unremarkable, and she has been using a levonorgestrel-releasing intrauterine device for contraception over the past two years. Her last menstrual period was three weeks ago. She reports having a new male sexual partner as of two months ago. Vital signs show a temperature of 37.6 C (99.7 F), blood pressure of 112/74 mm Hg, and a heart rate of 84/min. Abdominal palpation elicits mild tenderness in the bilateral lower quadrants but no rebound tenderness or guarding. On pelvic examination, the intrauterine device strings are visible at the cervical os. Purulent material is seen exuding from the endocervical canal. Bimanual examination demonstrates pronounced cervical motion tenderness and bilateral adnexal tenderness without discrete masses. A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?

  1. Administer intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; leave the intrauterine device in placeCevap
  2. B
    Administer intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; remove the intrauterine device
  3. C
    Admit the patient for intravenous cefoxitin and oral doxycycline; leave the intrauterine device in place
  4. D
    Remove the intrauterine device and submit it for microbial cultures prior to initiating antibiotics
  5. E
    Perform a transvaginal ultrasound to rule out a tubo-ovarian abscess prior to initiating antibiotics

Cevap

The most appropriate management is to administer outpatient antibiotics consisting of intramuscular ceftriaxone, oral doxycycline, and oral metronidazole, and to leave the intrauterine device in place.
This patient presents with classic signs of acute pelvic inflammatory disease (PID), including pelvic pain, purulent cervical discharge, cervical motion tenderness, and adnexal tenderness. Because she has mild-to-moderate symptoms without high fever, intractable vomiting, or evidence of a tubo-ovarian abscess, she can be safely managed in the outpatient setting. The recommended outpatient regimen consists of a single dose of intramuscular ceftriaxone plus a 14-day course of oral doxycycline and oral metronidazole. Importantly, in women who have an intrauterine device (IUD) in place, the device does not need to be removed initially. Standard practice is to leave the IUD in place, initiate empiric antibiotics, and reevaluate the patient in 48-72 hours. IUD removal is only considered if there is no clinical improvement after 2 to 3 days of appropriate antibiotic therapy.

Adım Adım Çözüm

1
Analyze the patient's symptoms and examination findings to establish a diagnosis.
The presence of lower abdominal pain, purulent cervical discharge, cervical motion tenderness, and adnexal tenderness confirms a clinical diagnosis of pelvic inflammatory disease (PID).
Identifying the clinical syndrome dictates the treatment pathway.
2
Evaluate the severity of the infection to determine the appropriate treatment setting.
The patient lacks criteria for inpatient admission (no high fever, intractable nausea/vomiting, or palpable adnexal mass), making her a candidate for outpatient management with ceftriaxone, doxycycline, and metronidazole.
Triage between inpatient and outpatient care is essential for appropriate resource utilization and patient safety.
3
Determine the management of the intrauterine device (IUD) in the setting of acute PID.
Current guidelines dictate that the IUD should be left in place during initial antibiotic therapy.
Removing the IUD does not improve short-term clinical outcomes but prematurely removes an effective form of contraception.

Anahtar Kavram

In patients with mild-to-moderate pelvic inflammatory disease and an intrauterine device (IUD) in place, the standard of care is to initiate outpatient empiric antibiotics and leave the IUD in place, reevaluating the patient's clinical response in 48 to 72 hours.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Gynecologic Infections

Bu konudan daha fazla soru